
Verrica Pharmaceuticals Announces Closing of $125 Million Debt Financing with OrbiMed
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced the closing this week of the previously announced $125 million debt financing with OrbiMed, a leading healthcare investment firm.
Verrica Pharmaceuticals Announces Closing of $125 Million Debt Financing with OrbiMed Read More